Welcome, Guest
Register
Sign In
Member Center
Sign Out
Register
Sign In
Go
Symbol Lookup
Loading...
Go
HOME
NEWS
U.S.
Asia
Europe
Economy
Energy
Inside Wealth
Politics
Technology
Blogs
Slideshows
Special Reports
Corrections
MARKETS
Pre-Markets
US
Europe
Asia
Stocks
Commodities
Currencies
Bonds
Funds
ETFs
EARNINGS
Calendar
Surprises
Highlights
INVESTING
Stock Blog
Personal Finance
CNBC Explains
Portfolio
Watchlist
Stock Screener
Fund Screener
Small Business
Franchising
Financing
Management
Video
VIDEO
Latest Video
Top Video
U.S. Video
Europe Video
Asia Video
CEO Interviews
Analyst Interviews
CNBC TV
CNBC U.S.
CNBC Asia-Pacific
CNBC Europe
CNBC World
CNBC Pro
Streaming Stock Quotes Are
Celgene Corp
(CELG :
)
Real Time Stock Quote | Source:
Extended Hours
---
Last Trade
---
*
After Hours Change
---
Volume
---
After Hours
---
Last Trade
---
*
Change
---
Volume
---
Trade Time
Symbol :
Go
[Find Symbol]
QUOTE
CHART
NEWS
PROFILE
EARNINGS
PEERS
FINANCIALS
OWNERSHIP
Stock Summary
Options Chain
CELG FEATURED NEWS & ANALYSIS
LATEST ABOUT THIS TOPIC ON CNBC.COM
More
Final Glance: Biotechnology companies
45 mins ago - The Associated Press
Midday Glance: Biotechnology companies
5 hrs ago - The Associated Press
Early Glance: Biotechnology companies
8 hrs ago - The Associated Press
Final Glance: Biotechnology companies
17 Jun 2013 - The Associated Press
Midday Glance: Biotechnology companies
17 Jun 2013 - The Associated Press
Early Glance: Biotechnology companies
17 Jun 2013 - The Associated Press
Cramer: A 'Nightmare Scenario' For Markets
17 Jun 2013
Monday's Market Roadmap
17 Jun 2013
Final Glance: Biotechnology companies
14 Jun 2013 - The Associated Press
Midday Glance: Biotechnology companies
14 Jun 2013 - The Associated Press
MORE FROM CNBC
More
Cramer: A 'Nightmare Scenario' For Markets
17 Jun 2013
Monday's Market Roadmap
17 Jun 2013
Cramer's Mad Dash: Celgene's Biotech Bounce
12 Jun 2013
Former Oracle Exec Hired At Salesforce.com
07 Jun 2013
S&P Best & Worst
06 Jun 2013
Cramer: Out with the New, In with the Old
03 Jun 2013 - CNBC.com
Just Another Manic Monday?
03 Jun 2013
Mad Money, June 3, 2013
03 Jun 2013
Nasdaq Check: Valeant-Bausch & Lomb Deal?
24 May 2013
MORE FROM OUR PARTNERS
More
An Interview With Elemer Piros: A Strong Year For Biotechs, Looking Fr...
7 hrs ago - Seeking Alpha
LATEST TRANSCRIPTS
More
Celgene Corporation's Management Presents at the Sanford C. Bernstein'...
30 May 2013 - Seeking Alpha
Celgene's Management Presents at 2013 UBS Global Healthcare Conference...
22 May 2013 - Seeking Alpha
PRESS RELEASES
More
Mei Pharma Initiates Phase II Clinical Trial Of Pracinostat And Vidaza...
10 hrs ago - PR Newswire
Advanced Treatment Methods, Significant Study Results, Conferences, an...
10 hrs ago - PR Newswire
Acetylon Pharmaceuticals Presents Encouraging Safety and Clinical Resp...
17 Jun 2013 - Business Wire
Research and Markets: Nanotechnology Drug Delivery Market in the US 20...
17 Jun 2013 - Business Wire
Oral Anti-Cancer Therapy REVLIMID?? (lenalidomide) Now Indicated as a ...
17 Jun 2013 - Business Wire
Oral Apremilast Achieves Statistical Significance for Primary and Seco...
14 Jun 2013 - Business Wire
Research and Markets: Global Nanotechnology Drug Delivery Market Repor...
13 Jun 2013 - Business Wire
Turkey's Non-Small-Cell Lung Cancer Drug Market Projected to Grow at 7...
13 Jun 2013 - PR Newswire
Acetylon Pharmaceuticals to Present Data Supporting ACY-1215 in Multip...
13 Jun 2013 - Business Wire
Research and Markets: Cancer Diagnostics Partnering Terms and Agreemen...
13 Jun 2013 - Business Wire
Markets
Economy
Companies
Top News & ANALYSIS
Google Facilitates Illegal Activity, Say State AGs
Yellen to Succeed Bernanke?
'Full-Speed Ahead' Before Fed Meeting
Adobe Earnings Beat but Future Earnings May Not
United Elite Status? Depends on How Much You Spend
Icahn Proposes Tender for 1.1 Billion Dell Shares
NYSE Bomb Plot Foiled by Surveillance Program: FBI
Home Builders Slow New Construction, Raise Prices
Forgot to 'Google' Your Financial Advisor?
Icahn Calls for Dell Tender
SPECIAL OFFER
Download Free Annual Report.